Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?

The prevalence and economic burden of atrial fibrillation (AF) are predicted to more than double over the next few decades. In addition to anticoagulation and treatment of concomitant cardiovascular conditions, early and standardized rhythm control therapy reduces cardiovascular outcomes as compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Kany, Shinwan, Reissmann, Bruno, Metzner, Andreas, Kirchhof, Paulus, Darbar, Dawood, Schnabel, Renate B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Spotlight Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208749/
https://www.ncbi.nlm.nih.gov/pubmed/33982075
http://dx.doi.org/10.1093/cvr/cvab153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208749/
https://www.ncbi.nlm.nih.gov/pubmed/33982075
http://dx.doi.org/10.1093/cvr/cvab153

Ejemplares similares